Home / XBIT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XBIT make money? Does XBIT have pricing power? What's the Earnings Whisper? Will XBIT profit more as the business scales? What is XBIT's management track record? Is XBIT's current price justified?

XBiotech Inc.

$2.19 -$0.19 (-7.98%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.17

Day Range

$2.18$2.2

Year Range

$2.09$3.44

Market Cap

66.77M

AVG Volume

36.84K

Trailing/Forward PE

-1.48/-

PEG ratio

0.03

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Revenue (USD)

XBIT Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	0
2023	0
2022	4.01M
2021	18.39M
2020	44M
2019	0
2018	0
2017	0
2016	0

Net Income (USD)

XBIT Net Income (USD) by year
Period	Net Income (USD)
2025	-45.54M
2024	-38.53M
2023	-24.56M
2022	-32.9M
2021	-17.41M
2020	-11.22M
2019	668.63M
2018	-21.14M
2017	-33.15M
2016	-52.76M

Operating Income (USD)

XBIT Operating Income (USD) by year
Period	Operating Income (USD)
2025	-55.69M
2024	-42.47M
2023	-37.51M
2022	-34.49M
2021	-25.08M
2020	-18.28M
2019	-31.23M
2018	-20.99M
2017	-34.06M
2016	-52.76M

EBITDA (USD)

XBIT EBITDA (USD) by year
Period	EBITDA (USD)
2025	-43.53M
2024	-36.21M
2023	-22.57M
2022	-30.97M
2021	-23.32M
2020	-16.04M
2019	-28.87M
2018	-18.56M
2017	-32.57M
2016	-52.06M

Cash Flows (USD)

XBIT Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-40.21M
2024	-32.27M
2023	-19.09M
2022	-9.54M
2021	65.92M
2020	-68.88M
2019	-18.47M
2018	-16.66M
2017	-35.05M
2016	-59.93M

EPS (USD)

XBIT EPS (USD) by year
Period	EPS (USD)
2025	-1.5
2024	-1.26
2023	-0.81
2022	-1.09
2021	-0.58
2020	-0.39
2019	18.51
2018	-0.58
2017	-0.96
2016	-1.61

Expenses (USD)

XBIT Expenses (USD) by year
Period	Expenses (USD)
2025	55.98M
2024	43.77M
2023	37.44M
2022	38.43M
2021	41.18M
2020	31.45M
2019	31.44M
2018	21.12M
2017	35.46M
2016	66.68M

Cash & Debt (USD)

XBIT Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	125.55M
2024	172.68M
2023	200.02M
2022	217.48M
2021	236.98M
2020	237.37M
2019	714.59M
2018	15.82M
2017	31.77M
2016	34.32M

Debt ratios

XBIT Debt ratios by year
Period	Debt ratios
2025	0.94
2024	1.44
2023	2.15
2022	2.19
2021	2.73
2020	2.47
2019	5.41
2018	0.11

Margins

XBIT Margins by year
Period	Margins
2022	83.77%
2021	68.36%
2020	21.47%

Return on Capital

XBIT Return on Capital by year
Period	Return on Capital
2025	-32.45%
2024	-21.14%
2023	-11.22%
2022	-13.69%
2021	-6.46%
2020	-3.22%
2019	88.49%
2018	-51.06%
2017	-55.1%
2016	-89.33%

Shares Outstanding

XBIT Shares Outstanding by year
Period	Shares Outstanding
2025	30.49M
2024	30.46M
2023	30.44M
2022	30.44M
2021	30.34M
2020	29.26M
2019	36.17M
2018	35.83M
2017	35.45M
2016	32.51M

Dividends (USD)

XBIT Dividends (USD) by year
Period	Dividends (USD)
2021	2.47

Employee Count

XBIT Employee Count by year
Period	Employee Count
2025	85
2024	92
2023	82
2022	85
2021	97
2020	91
2019	60
2018	56
2017	51
2016	106

Book Value Per Share (USD)

XBIT Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	4.6
2024	5.98
2023	7.19
2022	7.9
2021	8.88
2020	11.92
2019	20.89
2018	1.16
2017	1.7
2016	1.82

Total Assets (USD)

XBIT Total Assets (USD) by year
Period	Total Assets (USD)
2025	150.08M
2024	199.09M
2023	226.62M
2022	246.1M
2021	275.18M
2020	353.74M
2019	816.88M
2018	44.34M
2017	62.97M
2016	67.05M

PE Ratio

XBIT PE Ratio by year
Period	PE Ratio
Mar 21	0.86
Mar 21	0.8
Feb 21	0.81
Feb 21	0.85
Feb 21	0.87
Feb 21	0.86
Jan 21	0.8
Jan 21	0.72
Jan 21	0.7
Jan 21	0.75
Dec 20	0.67
Dec 20	0.72
Dec 20	0.73
Dec 20	0.81
Dec 20	0.82
Nov 20	0.83
Nov 20	0.75
Nov 20	0.84
Nov 20	0.79
Oct 20	0.73
Oct 20	0.78
Oct 20	0.82
Oct 20	0.85
Oct 20	0.78
Sep 20	0.81
Sep 20	0.91
Sep 20	0.81
Sep 20	0.78
Aug 20	0.81
Aug 20	0.79
Aug 20	0.74
Aug 20	0.81
Jul 20	0.78
Jul 20	0.82
Jul 20	0.81
Jul 20	0.79
Jul 20	0.78
Jun 20	0.78
Jun 20	0.76
Jun 20	0.71
Jun 20	0.78
May 20	0.75
May 20	0.77
May 20	0.77
May 20	0.85
May 20	0.85
Apr 20	0.74
Apr 20	0.74
Apr 20	0.72
Apr 20	0.62
Mar 20	0.53
Mar 20	0.51

Free Cash Flow Yield

XBIT Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-61.16%
Sep 26	-60.88%
Aug 26	-59.01%
Aug 26	-58.75%
Aug 26	-58.24%
Aug 26	-61.21%
Jul 26	-62.31%
Jul 26	-61.21%
Jul 26	-61.21%
Jul 26	-60.68%
Jul 26	-60.41%
Jun 26	-59.64%
Jun 26	-60.15%
Jun 26	-59.38%
Jun 26	-58.63%
May 26	-57.42%
May 26	-57.18%
May 26	-56.49%
May 26	-53.61%
May 26	-51.72%
Apr 26	-52.54%
Apr 26	-53.61%
Apr 26	-56.6%
Apr 26	-56.12%
Mar 26	-58.1%
Mar 26	-55.18%
Mar 26	-57.09%
Mar 26	-33.28%
Feb 26	-34.61%
Feb 26	-33.86%
Feb 26	-31.93%
Feb 26	-33%
Jan 26	-31.16%
Jan 26	-29.19%
Jan 26	-30.44%
Jan 26	-30.55%
Jan 26	-32.86%
Dec 25	-31.67%
Dec 25	-31.29%
Dec 25	-32.59%
Dec 25	-31.54%
Nov 25	-34.46%
Nov 25	-34.31%
Nov 25	-29.63%
Nov 25	-35.97%
Oct 25	-35.82%
Oct 25	-32.75%
Oct 25	-33.8%
Oct 25	-33.14%
Oct 25	-31.88%
Sep 25	-31.17%
Sep 25	-30.94%
Sep 25	-30.61%
Sep 25	-28.82%
Aug 25	-26.64%
Aug 25	-26.3%
Aug 25	-26.72%
Aug 25	-35.52%
Aug 25	-36.4%
Jul 25	-36.14%
Jul 25	-34.81%
Jul 25	-36.65%
Jul 25	-32.62%
Jun 25	-37.05%
Jun 25	-41.49%
Jun 25	-39.29%
Jun 25	-35.77%
May 25	-36.4%
May 25	-36.52%
May 25	-34.12%
May 25	-38.24%
May 25	-36.28%
Apr 25	-32.92%
Apr 25	-32.58%
Apr 25	-29.21%
Apr 25	-33.38%
Mar 25	-30.9%
Mar 25	-27.85%
Mar 25	-28.94%
Mar 25	-29.48%
Feb 25	-27.21%
Feb 25	-32.04%
Feb 25	-29.29%
Feb 25	-30.9%
Jan 25	-27.69%
Jan 25	-26.25%
Jan 25	-25.08%
Jan 25	-24.69%
Jan 25	-21.67%
Dec 24	-25.21%
Dec 24	-15.01%
Dec 24	-13.78%
Dec 24	-14.97%
Nov 24	-12.59%
Nov 24	-14.03%
Nov 24	-14.38%
Nov 24	-10.67%
Nov 24	-10.96%
Oct 24	-11.23%
Oct 24	-10.67%

Price to Sales

XBIT Price to Sales by year
Period	Price to Sales
Apr 24	798.45
Apr 24	815.7
Apr 24	938.46
Apr 24	832.95
Mar 24	824.83
Mar 24	760.92
Mar 24	599.6
Mar 24	649.31
Mar 24	649.31
Feb 24	654.39
Feb 24	598.59
Feb 24	596.56
Feb 24	550.9
Jan 24	426.11
Jan 24	471.77
Jan 24	507.28
Jan 24	408.87
Dec 23	405.82
Dec 23	397.71
Dec 23	471.77
Dec 23	423.07
Dec 23	403.79
Nov 23	363.21
Nov 23	386.04
Nov 23	399.73
Nov 23	64.26
Oct 23	61.49
Oct 23	58.03
Oct 23	60.42
Oct 23	63.03
Sep 23	63.34
Sep 23	67.03
Sep 23	69.95
Sep 23	74.1
Sep 23	73.18
Aug 23	87.01
Aug 23	76.87
Aug 23	78.25
Aug 23	43.53
Jul 23	43.97
Jul 23	47.96
Jul 23	45.1
Jul 23	47.87
Jun 23	51.51
Jun 23	52.38
Jun 23	53.68
Jun 23	47.26
Jun 23	44.31
May 23	47.44
May 23	42.93
May 23	29.05
May 23	25.43
Apr 23	26.11
Apr 23	26.26
Apr 23	27.02
Apr 23	27.4
Mar 23	26.19
Mar 23	25.28
Mar 23	25.96
Mar 23	12.38
Mar 23	12.42
Feb 23	11.94
Feb 23	13.12
Feb 23	14.24
Feb 23	15.39
Jan 23	16.46
Jan 23	15.57
Jan 23	17.28
Jan 23	13.4
Dec 22	13.01
Dec 22	11.42
Dec 22	11.49
Dec 22	11.83
Dec 22	12.61
Nov 22	11.79
Nov 22	12.61
Nov 22	13.01
Nov 22	9.81
Oct 22	9.81
Oct 22	9.31
Oct 22	10.08
Oct 22	10.44
Sep 22	9.97
Sep 22	10.25
Sep 22	11.05
Sep 22	11.38
Sep 22	11.19
Aug 22	11.85
Aug 22	12.62
Aug 22	14.16
Aug 22	11.25
Jul 22	11.06
Jul 22	11.34
Jul 22	11.17
Jul 22	12.47
Jul 22	12.07
Jun 22	12.54
Jun 22	10.97
Jun 22	12.13
Jun 22	12.77

Price/Operating Cashflow

XBIT Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Aug 22	2.53
Jul 22	2.48
Jul 22	2.55
Jul 22	2.51
Jul 22	2.8
Jul 22	2.71
Jun 22	2.82
Jun 22	2.47
Jun 22	2.72
Jun 22	2.87
May 22	2.69
May 22	2.7
May 22	2.76
May 22	3.04
Apr 22	3.39
Apr 22	3.36
Apr 22	3.64
Apr 22	3.81
Apr 22	3.98
Mar 22	3.88
Mar 22	4.19
Mar 22	3.85
Mar 22	4.03
Feb 22	4.22
Feb 22	4.17
Feb 22	4.34
Feb 22	4.17
Jan 22	4.48
Jan 22	4.39
Jan 22	4.97
Jan 22	4.85
Dec 21	4.77
Dec 21	4.84
Dec 21	4.94
Dec 21	5
Dec 21	4.73
Nov 21	5.48
Nov 21	5.43
Nov 21	6.31
Nov 21	5.84
Oct 21	5.38
Oct 21	5.17
Oct 21	4.85
Oct 21	4.75
Oct 21	4.86
Sep 21	5.26
Sep 21	5.9
Sep 21	5.76
Sep 21	5.84
Aug 21	5.92
Aug 21	5.71
Aug 21	5.86

Price to Book

XBIT Price to Book by year
Period	Price to Book
Sep 26	0.52
Sep 26	0.52
Aug 26	0.54
Aug 26	0.54
Aug 26	0.55
Aug 26	0.51
Jul 26	0.5
Jul 26	0.51
Jul 26	0.51
Jul 26	0.52
Jul 26	0.52
Jun 26	0.53
Jun 26	0.52
Jun 26	0.53
Jun 26	0.54
May 26	0.55
May 26	0.55
May 26	0.56
May 26	0.53
May 26	0.55
Apr 26	0.55
Apr 26	0.53
Apr 26	0.51
Apr 26	0.51
Mar 26	0.49
Mar 26	0.52
Mar 26	0.5
Mar 26	0.43
Feb 26	0.41
Feb 26	0.42
Feb 26	0.45
Feb 26	0.43
Jan 26	0.46
Jan 26	0.49
Jan 26	0.47
Jan 26	0.47
Jan 26	0.43
Dec 25	0.45
Dec 25	0.46
Dec 25	0.44
Dec 25	0.45
Nov 25	0.41
Nov 25	0.42
Nov 25	0.48
Nov 25	0.41
Oct 25	0.41
Oct 25	0.45
Oct 25	0.44
Oct 25	0.45
Oct 25	0.47
Sep 25	0.48
Sep 25	0.48
Sep 25	0.48
Sep 25	0.51
Aug 25	0.56
Aug 25	0.56
Aug 25	0.55
Aug 25	0.51
Aug 25	0.5
Jul 25	0.5
Jul 25	0.52
Jul 25	0.49
Jul 25	0.55
Jun 25	0.49
Jun 25	0.44
Jun 25	0.46
Jun 25	0.51
May 25	0.5
May 25	0.5
May 25	0.53
May 25	0.46
May 25	0.49
Apr 25	0.46
Apr 25	0.47
Apr 25	0.52
Apr 25	0.46
Mar 25	0.49
Mar 25	0.55
Mar 25	0.53
Mar 25	0.52
Feb 25	0.56
Feb 25	0.47
Feb 25	0.52
Feb 25	0.49
Jan 25	0.55
Jan 25	0.58
Jan 25	0.61
Jan 25	0.62
Jan 25	0.7
Dec 24	0.6
Dec 24	1.01
Dec 24	1.1
Dec 24	1.02
Nov 24	1.21
Nov 24	1.08
Nov 24	1.06
Nov 24	1.17
Nov 24	1.14
Oct 24	1.11
Oct 24	1.17

No video analysis for this stock yet. Request one from our team.

News: XBIT

globenewswire.com · 15 Jun 2026

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment

AI Analysis

XBiotech Inc.

Video analysis: XBIT

News: XBIT

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

Similar companies